Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

NEW METHOD TO ACTIVATE STREPTOMYCES SECONDARY METABOLISM CRYPTIC PATHWAYS

Project description

Regulation of Streptomyces metabolism opens new drug discovery paths

The bacterial genus Streptomyces is known for its capacity to produce natural and therapeutic compounds. Genomic annotation of Streptomyces has indicated the presence of cryptic secondary metabolite pathways, not expressed in the traditional screening programmes. Scientists of the EU-funded StrepCryptPath project have identified a Streptomyces coelicolor mutant strain that lacks a specific regulator of differentiation and secondary metabolism. This strain can produce secondary metabolites during its whole developmental cycle, including compounds encoded by several cryptic pathways. Therefore, researchers are developing strategies to inactivate the conserved regulator in Streptomyces, as an approach to activate Streptomyces' secondary metabolism. If successful, this approach could revolutionise the discovery of new secondary metabolites.

Objective

The aim of the StrepCrypPath is to test the industrial potential of a new approach to enhance Streptomyces secondary metabolism, discovered in our ERC-StG Strp-differentiation (280304) project. We discovered a pleiotropic regulator of differentiation and secondary metabolism in the S. coelicolor model strain. The S. coelicolor strain lacking this regulator is the first Streptomyces reported to produce secondary metabolites during its whole developmental cycle, including germination, the exponential growth phase and the stationary stage. S. coelicolor encodes 30 secondary metabolites, but only two are produced in high amounts under the culture conditions used in our lab. The expression of 15 secondary metabolite clusters (50% of the total), including 6 predicted to participate in secondary metabolite biosynthesis never observed in the lab (cryptic pathways), is activated/enhanced, in our mutant.

The gene encoding this new regulator is highly conserved in Streptomyces. We will explore if the inactivation of the orthologues of this regulatory gene in industrial streptomycetes causes the same phenotype observed in S. coelicolor: secondary metabolism and cryptic pathway activation. We will create integrative conjugative plasmids harbouring antisense mRNAs to inactivate this gene. We do not expect that this method will enhance and/or activate all secondary metabolite clusters. However, if as it happens in S. coelicolor, we can activate/enhance 50% of the secondary metabolite pathways, including several cryptic pathways, in any streptomycete, we can revolutionise the screening for new secondary metabolites from streptomycetes.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

ERC-POC - Proof of Concept Grant

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2018-PoC

See all projects funded under this call

Host institution

UNIVERSIDAD DE OVIEDO
Net EU contribution
€ 150 000,00
Address
CALLE SAN FRANCISCO 3
33003 OVIEDO
Spain
Region
Noroeste Principado de Asturias Asturias
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 150 000,00

Beneficiaries (1)